< Back to situations

[PERSON]

Drew Weissman

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [AU] [ES] [IT]

mRNA technology and personalized cancer vaccine research

2 clusters · 53 sources · last updated

Latest: Moderna and Merck mRNA melanoma vaccine reduces recurrence risk by 42%

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

[ACTIVE] [HEALTH] [US] [GR] [IT]

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ